These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36403006)

  • 1. Fluoxetine for the treatment of onychotillomania associated with obsessive-compulsive disorder: a case report.
    Aljhani S
    J Med Case Rep; 2022 Nov; 16(1):431. PubMed ID: 36403006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onychotillomania in the Setting of Homelessness.
    Rasul TF; Gulraiz S; Henderson A
    Cureus; 2022 Mar; 14(3):e22988. PubMed ID: 35415028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onychotillomania: A Chameleon-Like Disorder: Case Report and Review of Literature.
    Sidiropoulou P; Sgouros D; Theodoropoulos K; Katoulis A; Rigopoulos D
    Skin Appendage Disord; 2019 Feb; 5(2):104-107. PubMed ID: 30815444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
    Koran LM; Cain JW; Dominguez RA; Rush AJ; Thiemann S
    Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder.
    Frenkel A; Rosenthal J; Nezu A; Winston A
    Mt Sinai J Med; 1990 Nov; 57(6):348-52. PubMed ID: 2079952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the Yale-Brown Obsessive-Compulsive Scale severity scale to understand the routes for symptomatic improvement in obsessive-compulsive disorder.
    Costa DLDC; Barbosa VS; Requena G; Shavitt RG; Pereira CAB; Diniz JB
    J Psychopharmacol; 2017 Oct; 31(10):1312-1322. PubMed ID: 28441896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onychotillomania: 2 case reports.
    Inglese M; Haley HR; Elewski BE
    Cutis; 2004 Mar; 73(3):171-4. PubMed ID: 15074344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine treatment of obsessive-compulsive disorder.
    Turner SM; Jacob RG; Beidel DC; Himmelhoch J
    J Clin Psychopharmacol; 1985 Aug; 5(4):207-12. PubMed ID: 3894437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open trial of fluoxetine in obsessive-compulsive disorder.
    Jenike MA; Buttolph L; Baer L; Ricciardi J; Holland A
    Am J Psychiatry; 1989 Jul; 146(7):909-11. PubMed ID: 2787123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine in the treatment of obsessive compulsive disorder.
    Fontaine R; Chouinard G
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):605-8. PubMed ID: 3878975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nail-Associated Body-Focused Repetitive Behaviors: Habit-Tic Nail Deformity, Onychophagia, and Onychotillomania.
    Cohen PR
    Cureus; 2022 Mar; 14(3):e22818. PubMed ID: 35382180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-onset obsessive-compulsive symptoms after brain infarctions treated with paroxetine.
    Muneoka K; Shirayama Y; Kon K; Kawabe M; Kimura S
    Clin Neuropharmacol; 2011; 34(6):260-1. PubMed ID: 22104637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome.
    Kurlan R; Como PG; Deeley C; McDermott M; McDermott MP
    Clin Neuropharmacol; 1993 Apr; 16(2):167-72. PubMed ID: 8477412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of transcranial direct current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder: a randomized, double-blind, sham-controlled, clinical trial.
    Yoosefee S; Amanat M; Salehi M; Mousavi SV; Behzadmanesh J; Safary V; Yoonesi A; Salehi B
    BMC Psychiatry; 2020 Nov; 20(1):570. PubMed ID: 33256659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience.
    Riddle MA; Hardin MT; King R; Scahill L; Woolston JL
    J Am Acad Child Adolesc Psychiatry; 1990 Jan; 29(1):45-8. PubMed ID: 2295577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.